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Supporting Information 
 
Figure S1 
  
 
 
Figure S1: Gd-labelling of multiwalled carbon nanotubes. (A) Gd-labelling efficiency at different concentrations 
of Gadolinium. The optimal concentration of gadolinium for CNT labelling was found to be for 10 equivalents of 
gadolinium relative to the DTPA ligand on the CNT backbone. (B) 1-week stability of the Gd-labelling on the 
carbon nanotubes in (i) water and in (ii) mouse serum. Free gadolinium concentration was monitored overtime using 
UV-Visible spectroscopy in water and using ICP-MS in mouse serum. 
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Figure S2 
 
 
 
Figure S2: Energy Dispersive X-Ray Spectroscopy (EDX) of: (A) Gd-CNTs; and (B) unlabelled CNTs. 
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Figure S3 
 
 
 
 
 
Figure S3: T2-weighted characterisation and contrast efficiency of Gd-CNTs. Transversal relaxation rates R2 at 
increasing Gd concentrations ranging from 0.002 mM to 0.04 mM; determination of the contrast efficiency r2 of Gd-
CNTs that was found to be around 76.1 mM
-1
.s
-1
 (slope of the curve). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
y = 76.145x + 3.5279
R² = 0.9871
0
1
2
3
4
5
6
7
8
0 0.02 0.04
R
2
[1
/s
]
Gd[mM]
4 
 
Figure S4 
 
 
 
 
Figure S4: unlabelled and Gd-labelled CNT internalisation in HUVECs exposed for (A) 4 hours; and (B) 24 
hours at 20 µg/ml of CNTs. The internalisation was monitored overtime by optical microscopy comparing phase 
contrast versus bright field wherein unexposed cells have no contrast. 
 
 
 
